Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Empirical Formula (Hill Notation):
C22H29N3O3S3
CAS Number:
Molecular Weight:
479.68
UNSPSC Code:
12352200
NACRES:
NA.77
Product Name
L-F001, ≥98% (HPLC)
InChI
1S/C22H29N3O3S3/c26-22(8-2-1-6-19-10-16-29-30-19)24-12-4-13-25(15-14-24)31(27,28)21-7-3-5-18-17-23-11-9-20(18)21/h3,5,7,9,11,17,19H,1-2,4,6,8,10,12-16H2/t19-/m1/s1
InChI key
NWTRUKNNHUXONB-LJQANCHMSA-N
SMILES string
O=C(CCCC[C@@H]1CCSS1)N2CCN(S(C3=CC=CC4=C3C=CN=C4)(=O)=O)CCC2
assay
≥98% (HPLC)
form
oil
storage condition
desiccated
color
colorless to light brown
storage temp.
2-8°C
Related Categories
Biochem/physiol Actions
L-F001 is a multifunctional, brain penetrant and potent Rho-associated protein kinase (ROCK) inhibitor that protects the PC12 cells from paraquat induced cytotoxicity. L-F001 suppresses neuroinflammation in vitro and in vivo.
multifunctional, brain penetrant and potent Rho-associated protein kinase (ROCK) inhibitor
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Jingkao Chen et al.
European journal of pharmacology, 806, 1-9 (2017-03-23)
Microglia and astrocytes are largely responsible for inflammatory injury in the brain of Alzheimer's disease (AD). Increasing evidence has indicated that Rho kinase (ROCK) plays an important role in the regulation of neuroinflammation. Previously, we synthesized a new chemical entity
Liting Luo et al.
Neurochemical research, 42(2), 615-624 (2017-01-13)
Amounting evidences demonstrated that Rho/Rho-associated kinase (ROCK) might be a novel target for the therapy of Parkinson's disease (PD). Recently, we synthesized L-F001 and revealed it was a potent ROCK inhibitor with multifunctional effects. Here we investigated the effects of
Wei Shen et al.
Biochemical and biophysical research communications, 464(3), 794-799 (2015-07-19)
Paraquat (PQ) was demonstrated to induce dopaminergic neuron death and is used as a Parkinson's disease (PD) mimetic. Amounting evidences demonstrated that Rho/ROCK may a novel target for the therapy of PD. Previously we synthesized L-F001 and proved it is
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service